Everolimus approval now includes prevention of liver transplant rejectionClinical Endocrinology News Digital NetworkThe approved indication states that in liver transplant recipients, everolimus is used in combination with the calcineurin inhibitor tac…
|
Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus …
News-Medical.net In this issue of the Journal of Clinical Investigation, Tarek Fahmy and colleagues at Yale University report the development of a nanogel-based delivery system that targets an immunosuppressive drug (mycophenolic acid) directly to tissues associated … Nanogels offer new way to attack lupusR & D Magazine |
|
A nanogel-based treatment for lupus
Medical Xpress In this issue of the Journal of Clinical Investigation, Tarek Fahmy and colleagues at Yale University report the development of a nanogel-based delivery system that targets an immunosuppressive drug (mycophenolic acid) directly to tissues associated … Nanogels offer new way to attack lupusR & D Magazine |
Long-term use of corticosteroids may be linked to infectious keratitis after PKHealioInfectious keratitis in eyes that have undergone penetrating keratoplasty may be related to extended use of corticosteroids, according to a study. The retrospective co…
Promyleocytic leukemia gene goes up significantly in post treatment of mTOR …News-Medical.netFurther, they showed that PML upregulation made the tumor cells resistant to mTOR inhibitors, and that if they suppressed the ability of the tumor cells to u…
Novel Combination Therapy Shuts Down Escape Route, Killing Glioblastoma …Science Daily (press release)Further, they showed that PML upregulation made the tumor cells resistant to mTOR inhibitors, and that if they suppressed the ability of the tumor c…
Wary of steroids: New asthma test helps doctors prescribe treatmentsThe MissoulianA new, noninvasive breath test called fractional exhaled nitric oxide, or FeNO, has taken away much of the guess work about whether a patient should be on inhaled cortico…
|
Novartis Drug Zortress® Is First In Over A Decade Approved By FDA To Prevent …
Pharmaceutical Online (press release) 15, 2013 /PRNewswire/ — Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress® (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant. … of chronic renal failure was … Label Expansion for NVS’ Zortress – Analyst BlogNASDAQ |
 MedPage Today |
Novartis nabs another FDA-approved indication for everolimus
FiercePharma Turns out, everolimus is becoming quite the franchise for Novartis ($NVS). Sold under the Afinitor and Votubia names for tumor treatment and as Zortress and Certican for transplant patients, everolimus is one of the Swiss drugmaker’s lead drugs in the … FDA Approves Everolimus for Liver RejectionMedPage Today Novartis’ Zortress cleared by FDA for liver transplantsPMLiVE Novartis drug Zortress is first in over a decade approved by FDA to prevent …PipelineReview.com (press release) Monthly Prescribing Reference –Motley Fool –PharmaTimes all 9 news articles » |
MedPage Today |
FDA Approves Everolimus for Liver Rejection
MedPage Today Despite the similarity in generic names, everolimus and tacrolimus are in different drug classes. Whereas everolimus is an mTOR inhibitor (similar to sirolimus, also known as rapamycin and sold as Rapamune), tacrolimus is a calcineurin inhibitor. Novartis’ Zortress cleared by FDA for liver transplantsPMLiVE Novartis drug Zortress is first in over a decade approved by FDA to prevent …PipelineReview.com (press release) FDA approves Zortress to prevent liver transplant rejectionHealio PharmaTimes –Pharmaceutical Business Review all 6 news articles » |